DEF: Focus Universal Seeks Shareholder Approval for Stock Authorization Increase and Board Elections

Focus Universal is holding its annual shareholder meeting on June 20, 2025, to vote on director elections, auditor ratification, increasing authorized shares, and executive compensation.

Summary

• Focus Universal Inc. will hold its 2025 Annual Meeting of Shareholders on June 20, 2025, at its headquarters in Ontario, California.
• Shareholders will vote on several proposals, including the election of five directors, ratification of the company's auditor, and amendments to the Articles of Incorporation.
• The proposed amendments include increasing the number of authorized common shares from 15,000,000 to 25,000,000 and authorizing 5,000,000 shares of preferred stock.
• Shareholders will also cast advisory votes on executive compensation and the frequency of future executive compensation votes.
• The Board of Directors recommends voting for all proposals.
• The record date for determining shareholders eligible to vote is April 21, 2025.
• The company's outstanding shares of common stock as of December 31, 2024, were 7,153,647.
• The company is providing proxy materials online and intends to mail the Notice of Annual Meeting and accompanying Proxy Statement to shareholders on or about the Record Date.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting standard corporate governance matters and proposals. The related party transactions and the late filing by Dr. Lee are slight negatives, but overall the document is routine.

Positives

• The proposed increase in authorized shares provides the company with greater flexibility for future financing and strategic transactions.
• The authorization of preferred stock offers additional options for raising capital and structuring deals.
• The Board is actively engaged in corporate governance, with established committees and regular meetings.
• The company has a Code of Business Conduct and Ethics and an Insider Trading Policy in place.
• The Board is composed of a majority of independent directors.

Negatives

• The document mentions past related party transactions, including loans from shareholders and the CEO, which could raise concerns about conflicts of interest.
• The company had loans with related persons, including a $1,000,000 loan from Golden Sunrise Investment LLC and a $300,000 loan from the CEO, Desheng Wang.
• Dr. Edward Lee did not timely file a Form 4 to report certain indirect transfers of shares to beneficially owned entities, all of which occurred on or about September 25, 2024.

Risks

• The availability of additional authorized shares may have the effect of discouraging a merger, tender offer, proxy contest, or other attempt to obtain control of the Company.
• Subsequent issuance of shares of Common Stock, other than on a pro-rata basis to all shareholders, would reduce each shareholders proportionate interest in the Company.
• If the proposed amendments to the Articles of Incorporation are not approved, the company may have limited flexibility in pursuing future financing and strategic opportunities.

Future Outlook

The company aims to use the increased authorized shares for various corporate purposes, including raising capital, strategic transactions, and equity incentive grants, but has no definitive plans at this time.

Management Comments

• The Board believes that the Common Stock Proposal and Preferred Stock Proposal are in the Companys best interests because they would increase the number of shares of authorized Common Stock and authorize Preferred Stock.
• This added flexibility would allow the Company to issue shares of Common Stock and/or Preferred Stock in the future as needed for various corporate purposes, including, but not limited to, raising capital, engaging in strategic transactions, such as mergers, acquisitions, partnerships, joint ventures, divestitures, and other business combinations, effectuating stock splits or stock dividends, as well as other general corporate transactions, and providing equity incentive grants under employee stock plans.

Industry Context

The document does not provide specific industry context beyond the general need for capital and strategic flexibility, but the proposals are common for publicly traded companies seeking to grow and adapt to market conditions.

Comparison to Industry Standards

• The proxy statement does not provide specific comparisons to industry standards.
• However, the proposals to increase authorized shares and authorize preferred stock are common practices among publicly traded companies to provide flexibility for future financing and strategic transactions.
• Companies like Apple, Microsoft, and Amazon routinely seek shareholder approval for similar measures to maintain financial flexibility.

Related Party Transactions

• On September 7, 2023, the Company entered into a loan agreement with Golden Sunrise Investment LLC in the amount of $1,000,000.
• On March 5, 2024, the Company entered into an addendum to the loan agreement with Golden Sunrise Investment LLC, a related party obtaining an additional secured loan amount of $300,000 at an annual interest rate of 12% which is due September 7, 2024.
• On April 2, 2024, the Company entered into a two-year loan agreement with the Companys CEO Desheng Wang for the amount of $300,000.
• The Company and Dr. Desheng Wang, Chief Executive Officer, Secretary, and Director of the Company entered into a Subscription Agreement pursuant to which the Company agreed to issue and sell 100,000 shares of the Companys Common Stock for $300,000 in cash.
• The Company and Dr. Edward Lee, Chairman of the Board of the Company entered into a Subscription Agreement pursuant to which the Company agreed to issue and sell 100,000 shares of the Companys Common Stock for $300,000 in cash.

Stakeholder Impact

• Shareholders will have the opportunity to influence the company's direction through their votes.
• Employees may be affected by changes in executive compensation and equity incentive plans.
• The company's ability to raise capital and pursue strategic transactions could impact its long-term viability and success, affecting all stakeholders.

Next Steps

• Shareholders to vote on the proposals outlined in the proxy statement.
• Board to determine whether to file the Amended and Restated Articles with the Secretary of State of the State of Nevada, based on shareholder vote and its own discretion.
• The company will announce preliminary voting results at the Annual Meeting and publish final results in a Current Report on Form 8-K.

Key Dates

Keywords

proxy statement, annual meeting, shareholders, board of directors, common stock, preferred stock, executive compensation, auditor ratification, corporate governance, authorized shares